Cellectis
CLLS
31 hedge funds and large institutions have $26.1M invested in Cellectis in 2024 Q1 according to their latest regulatory filings, with 3 funds opening new positions, 8 increasing their positions, 6 reducing their positions, and 5 closing their positions.
33% more repeat investments, than reductions
Existing positions increased: 8 | Existing positions reduced: 6
0.05% less ownership
Funds ownership: 13.79% → 13.73% (-0.05%)
9% less funds holding
Funds holding: 34 → 31 (-3)
14% less capital invested
Capital invested by funds: $30.5M → $26.1M (-$4.35M)
40% less first-time investments, than exits
New positions opened: 3 | Existing positions closed: 5
79% less call options, than puts
Call options by funds: $17K | Put options by funds: $82K
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Principal Financial Group
Des Moines,
Iowa
|
+$68.9K |
| 2 |
Baillie Gifford & Co
Edinburgh,
United Kingdom
|
+$29.3K |
| 3 |
LPL Financial
San Diego,
California
|
+$25.3K |
| 4 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
+$22.5K |
| 5 |
HI
Harbour Investments
Madison,
Wisconsin
|
+$16.9K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Morgan Stanley
New York
|
-$189K |
| 2 |
Citadel Advisors
Miami,
Florida
|
-$54.8K |
| 3 |
Qube Research & Technologies (QRT)
London,
United Kingdom
|
-$11.5K |
| 4 |
Osaic Holdings
Scottsdale,
Arizona
|
-$9.68K |
| 5 |
TVAMP
Tennessee Valley Asset Management Partners
Knoxville,
Tennessee
|
-$7.48K |
CLLS Hedge Fund Activity: Q1 2024 in Review
31 of the 6,942 institutional investors tracked by Wall St. Rank reported a position in Cellectis (CLLS) for Q1 2024, worth a combined $26.1M — down 14% from $30.5M a quarter earlier.
Sellers outnumbered buyers: 5 funds closed out of CLLS and 3 opened new positions — a net loss of 2 holders — while 6 trimmed existing stakes and 8 added.
The largest buyer was Principal Financial Group, adding an estimated $68.9K. The largest seller was Morgan Stanley, cutting an estimated $189K.
- 31 institutional investors held Cellectis (CLLS) as of Q1 2024, down from 34 in Q4 2023.
- Funds reported $26.1M of Cellectis stock for Q1 2024, down 14% quarter-over-quarter.
- 3 funds opened new Cellectis positions in Q1 2024 and 5 closed out, a net change of -2 holders.
- The largest Cellectis buyer in Q1 2024 was Principal Financial Group, an estimated $68.9K added.
- The largest Cellectis seller in Q1 2024 was Morgan Stanley, an estimated $189K sold.
Based on aggregated 13F filings for Q1 2024.